Tore Curstedt Selected Research

CHF5633

1/2021	Impact of synthetic surfactant CHF5633 with SP-B and SP-C analogues on lung function and inflammation in rabbit model of acute respiratory distress syndrome.
10/2016	The new generation synthetic reconstituted surfactant CHF5633 suppresses LPS-induced cytokine responses in human neonatal monocytes.
1/2016	Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14+ Monocytes.
1/2014	Effects of Natural versus Synthetic Surfactant with SP-B and SP-C Analogs in a Porcine Model of Meconium Aspiration Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tore Curstedt Research Topics

Disease

16	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2021 - 11/2003
5	Lung Diseases (Lung Disease) 12/2021 - 01/2005
4	Inflammation (Inflammations) 01/2021 - 01/2016
4	Pneumonia (Pneumonitis) 01/2019 - 03/2006
3	Lung Injury 01/2021 - 07/2004
3	Meconium Aspiration Syndrome 01/2014 - 01/2003
2	Respiratory Tract Diseases (Respiratory Tract Disease) 05/2005 - 01/2005
1	Edema (Dropsy) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Hyperoxia 01/2020
1	Infections 01/2019
1	Newborn Respiratory Distress Syndrome 01/2016
1	Body Weight (Weight, Body) 06/2010
1	Respiratory Distress Syndrome In Premature Infants 04/2008

Drug/Important Bio-Agent (IBA)

25	Surface-Active Agents (Surfactants)IBA 12/2021 - 01/2003
5	Pulmonary Surfactants (Pulmonary Surfactant)IBA 01/2021 - 03/2006
4	CHF5633IBA 01/2021 - 01/2014
4	poractant alfa (Curosurf)FDA Link 01/2021 - 03/2006
3	Peptides (Polypeptides)IBA 12/2021 - 06/2010
3	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2021 - 04/2010
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2016 - 01/2007
3	Proteins (Proteins, Gene)FDA Link 04/2008 - 01/2005
2	Interleukin-8 (Interleukin 8)IBA 01/2021 - 05/2017
2	CytokinesIBA 01/2021 - 10/2016
2	Colistin (Coly-Mycin)FDA Link 01/2019 - 05/2017
2	Phosphorylcholine (Phosphocholine)IBA 01/2012 - 06/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2020
1	AntagomirsIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	Polymyxins (Polymyxin)IBA 05/2017
1	Caffeine (No Doz)FDA LinkGeneric 01/2014
1	Oxygen (Dioxygen)IBA 01/2014
1	Fibrinogen (Factor I)FDA Link 09/2012
1	Pulmonary Surfactant-Associated Protein BIBA 04/2008
1	Therapeutic UsesIBA 01/2003
1	Dextrans (Dextran)FDA Link 01/2003

Therapy/Procedure

5	Therapeutics 12/2021 - 01/2003
1	Cesarean Section (Caesarean Section) 01/2020
1	Mechanical Ventilators (Ventilator) 01/2020
1	Topical Administration 05/2017
1	Artificial Respiration (Mechanical Ventilation) 05/2005
1	Continuous Positive Airway Pressure 05/2005